Month: September 2023

– Topline results from this study are expected in early Q1 2024 – Celltrion has a right of first negotiation for RT-111 following positive Phase 1 results SAN JOSE, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the initiation of a Phase 1 clinical trial to evaluate the safety and tolerability of RT-111, an orally administered RaniPill®GO capsule containing an ustekinumab biosimilar, CT-P43. Topline results from this study are expected early in the first quarter of 2024. Ustekinumab is a human IgG1қ monoclonal antibody that binds with specificity to the p40 protein subunit used by both the interleukin-12 and interleukin-23 (IL-12 and...

EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, 2023 in Boston, Massachusetts. The details of NuCana’s presentations at the meeting are as follows: Abstract title: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)Poster number: B048Session: Poster Session BSession date and time: Friday, October 13 from 12:30pm-4:00pmPresenting Author: Dr. Khurum Khan Abstract title: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic...

PLANO, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce focused financial technology company, announced that Orlando Zayas, CEO, and Nancy Walsh, CFO, will participate in the Sidoti Small-Cap Conference on Thursday, September 21, 2023. Orlando Zayas and Nancy Walsh will host a presentation and Q&A session at 1:00 PM ET. A live audio webcast and replay will be available on the Company’s Investor Relations website at https://ir.katapultholdings.com/. About KatapultKatapult is a technology driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchasing of everyday durable goods for underserved U.S. non-prime consumers. Through our point-of-sale (POS) integrations and innovative, mobile app featuring...

HOUSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”) a leader in the specialty property and casualty (P&C) market, announced it is expanding its coverages in the healthcare sector adding a new solution catering to the distinct needs of E&S individual providers, including physicians. The healthcare landscape continues to present new challenges and opportunities for healthcare professionals, especially for individual providers and physicians. The demand for this type of coverage has outpaced the insurance market’s capacity and capabilities, resulting in a growing need for bespoke solutions for healthcare professionals. “We understand the critical role that individual providers and physicians play in the healthcare...

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available  Evaxion’s proprietary AI-platforms EDEN™ and RAVEN™ will be utilized for rapid design of a completely novel vaccine candidate capable of eliciting both a humoral (antibody) and cellular immune response to the pathogen Collaborative and co-funded project between two companies with strong scientific alignment and complementary skill sets and capabilities This collaboration underlines Evaxion’s strategic focus of harnessing the power of AI to identify new targets significantly more efficiently than traditional methodsCOPENHAGEN, Denmark, Sept. 18, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development...

CHARLOTTE, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Burke Francis and Christopher Francis, who have more than 80 years of combined experience, have joined LPL Financial to launch an exclusive family-focused office and independent practice, The Francis Group at LPL. They chose to affiliate with LPL’s supported independence model, LPL Strategic Wealth Services. The Francis Group reported having served approximately $1.2 billion in advisory, brokerage and retirement plan assets*. They join from Morgan Stanley. Since 1966, Burke Francis steadily built the Los Angeles area practice from the ground up by specializing in asset management for high-net-worth individuals. His son, Chris, joined the business in 1998, after working in real estate development and numerous venture backed companies. Burke...

Company has repurchased 713,831 shares of common stock to date and is upsizing the program NEW CANAAN, Conn., Sept. 18, 2023 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today provided an update regarding its $10 million common share repurchase program. To date, the Company has acquired 713,831 shares of common stock at an average price, including commissions, of $12.96 per share, utilizing approximately $9.3 million of the original $10 million authorization. Thus, on September 15, 2023, the Company’s board of directors authorized a $10 million increase to the Company’s existing share repurchase program and extended the duration to conclude on December 31, 2024, giving the Company approximately $10.7...

Camarillo, CA., Sept. 18, 2023 (GLOBE NEWSWIRE) — Sacks Parente Golf, Inc. (NASDAQ:SPGC), (the “Company” or “Sacks Parente”), a technology-forward golf company with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related accessories, reports its financial results for the quarter ended June 30, 2023, and provides a business update. Recent Corporate HighlightsClosed Initial Public Offering (IPO) transaction in mid-August that raised $11.6 million in proceeds, net of underwriting fees Introduced the Innovative Series 91 “The Duke” putter inspired by PGA TOUR Champions player Ken Duke Ken Duke won his first PGA TOUR Champions title at the Shaw Charity Classic using a Sacks Parente Series 66 Anser-style putterTimothy Triplett, Sacks Parente Golf’s Chief Executive Officer,...

CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the Catalyst’s senior management team, will participate in the 2023 Cantor Global Healthcare Conference which will be held on September 26-28, 2023. Presentation Details: Event: 2023 Cantor Global Healthcare ConferenceDate: September 26, 2023Time: 11:05 A.M. ETWebcast Link: https://wsw.com/webcast/cantor19/cprx/2116653 The webcast of the presentation will be available on the Company’s website, and a replay will be accessible for at least 14 days. About...